share_log

Phreesia (NYSE:PHR) Receives New Coverage From Analysts at KeyCorp

Phreesia (NYSE:PHR) Receives New Coverage From Analysts at KeyCorp

Phreesia(紐約證券交易所代碼:PHR)從KeyCorp的分析師那裏獲得新的報道
Defense World ·  2022/09/16 05:22

KeyCorp started coverage on shares of Phreesia (NYSE:PHR – Get Rating) in a research note published on Thursday morning, The Fly reports. The firm issued an overweight rating on the stock.

據The Fly報道,KeyCorp在週四上午發佈的一份研究報告中開始報道Phreesia(NYSE:PHR-GET Rating)的股票。該公司對該股發佈了增持評級。

Other research analysts have also issued research reports about the stock. Raymond James decreased their price target on shares of Phreesia from $45.00 to $34.00 in a research report on Monday, June 6th. Canaccord Genuity Group decreased their price target on shares of Phreesia from $37.00 to $36.00 and set a buy rating on the stock in a research report on Thursday, September 8th. Royal Bank of Canada lifted their price target on shares of Phreesia from $20.00 to $22.00 and gave the stock a sector perform rating in a research report on Thursday, September 8th. JMP Securities lowered their price objective on shares of Phreesia from $50.00 to $34.00 and set a market outperform rating on the stock in a research report on Friday, June 3rd. Finally, SVB Leerink lifted their price objective on shares of Phreesia from $27.00 to $31.00 and gave the stock a market perform rating in a research report on Thursday, September 8th. Three research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of Moderate Buy and a consensus price target of $35.92.

其他研究分析師也發佈了關於該股的研究報告。雷蒙德·詹姆斯在6月6日星期一的一份研究報告中將Phreesia的股票目標價從45.00美元下調至34.00美元。Cancord Genuity Group在9月8日週四的一份研究報告中將Phreesia的股票目標價從37.00美元下調至36.00美元,並對該股設定了買入評級。9月8日,加拿大皇家銀行在一份研究報告中將Phreesia股票的目標價從20.00美元上調至22.00美元,並給出了該股的行業表現評級。JMP證券將Phreesia股票的目標價從50.00美元下調至34.00美元,並在6月3日星期五的一份研究報告中對該股設定了表現優於市場的評級。最後,SVB Leerink將Phreesia股票的目標價從27.00美元上調至31.00美元,並在9月8日星期四的一份研究報告中給出了該股的市場表現評級。三位研究分析師對該股的評級為持有,十位分析師給予該公司買入評級。根據MarketBeat的數據,該公司目前的共識評級為適度買入,共識目標價為35.92美元。

Get
到達
Phreesia
費雷西亞
alerts:
警報:

Phreesia Price Performance

Phreesia性價比

NYSE PHR opened at $28.72 on Thursday. Phreesia has a 12 month low of $13.19 and a 12 month high of $76.10. The company has a debt-to-equity ratio of 0.01, a current ratio of 4.40 and a quick ratio of 4.40. The firm has a market capitalization of $1.51 billion, a PE ratio of -8.23 and a beta of 0.75. The company's 50 day simple moving average is $24.63 and its 200 day simple moving average is $24.11.

紐約證交所PHR週四開盤報28.72美元。Phreesia的12個月低點為13.19美元,12個月高位為76.10美元。該公司的債務權益比為0.01,流動比率為4.40,速動比率為4.40。該公司的市值為15.1億美元,市盈率為-8.23,貝塔係數為0.75。該公司的50日簡單移動均線切入位為24.63美元,200日簡單移動均線切入位為24.11美元。

Insider Buying and Selling at Phreesia

Phreesia的內幕買賣

In related news, SVP Michael J. Davidoff sold 5,046 shares of Phreesia stock in a transaction on Friday, June 24th. The shares were sold at an average price of $25.11, for a total value of $126,705.06. Following the completion of the sale, the senior vice president now owns 110,509 shares of the company's stock, valued at approximately $2,774,880.99. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, SVP Michael J. Davidoff sold 1,404 shares of Phreesia stock in a transaction on Thursday, July 21st. The shares were sold at an average price of $25.00, for a total value of $35,100.00. Following the completion of the sale, the senior vice president now owns 108,312 shares of the company's stock, valued at approximately $2,707,800. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Michael J. Davidoff sold 5,046 shares of Phreesia stock in a transaction on Friday, June 24th. The shares were sold at an average price of $25.11, for a total transaction of $126,705.06. Following the completion of the sale, the senior vice president now directly owns 110,509 shares of the company's stock, valued at approximately $2,774,880.99. The disclosure for this sale can be found here. Insiders sold 9,055 shares of company stock valued at $228,467 in the last quarter. Company insiders own 5.50% of the company's stock.
在相關新聞中,高級副總裁邁克爾·J·戴維杜夫在6月24日星期五的一次交易中出售了5046股Phreesia股票。這些股票的平均價格為25.11美元,總價值為126,705.06美元。出售完成後,高級副總裁現在擁有該公司110,509股股票,價值約2,774,880.99美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,可以通過美國證券交易委員會網站訪問該文件。在相關新聞中,高級副總裁邁克爾·J·戴維杜夫在7月21日星期四的一次交易中出售了1,404股Phreesia股票。這些股票的平均價格為25.00美元,總價值為35100.00美元。出售完成後,高級副總裁現在擁有該公司108,312股股票,價值約2,707,800美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,可以通過美國證券交易委員會網站訪問該文件。此外,高級副總裁邁克爾·J·戴維杜夫在6月24日(星期五)的一次交易中出售了5046股Phreesia股票。這些股票以25.11美元的平均價格出售,總成交金額為126,705.06美元。出售完成後,高級副總裁現在直接持有公司股票110,509股,價值約2,774,880.99美元。此次拍賣的披露信息可在此處找到。內部人士在上個季度出售了9,055股公司股票,價值228,467美元。公司內部人士持有該公司5.50%的股份。

Institutional Investors Weigh In On Phreesia

機構投資者買入Phreesia股票

Several institutional investors and hedge funds have recently modified their holdings of PHR. Assetmark Inc. raised its holdings in Phreesia by 42.2% in the 2nd quarter. Assetmark Inc. now owns 1,685 shares of the company's stock worth $42,000 after acquiring an additional 500 shares during the period. US Bancorp DE raised its holdings in Phreesia by 6.6% in the 2nd quarter. US Bancorp DE now owns 8,270 shares of the company's stock worth $207,000 after acquiring an additional 509 shares during the period. Advisor Group Holdings Inc. raised its holdings in Phreesia by 63.4% in the 4th quarter. Advisor Group Holdings Inc. now owns 1,319 shares of the company's stock worth $55,000 after acquiring an additional 512 shares during the period. Edmond DE Rothschild Holding S.A. raised its holdings in Phreesia by 2.2% in the 1st quarter. Edmond DE Rothschild Holding S.A. now owns 37,650 shares of the company's stock worth $992,000 after acquiring an additional 800 shares during the period. Finally, Arizona State Retirement System raised its holdings in Phreesia by 6.6% in the 2nd quarter. Arizona State Retirement System now owns 13,192 shares of the company's stock worth $330,000 after acquiring an additional 815 shares during the period. Institutional investors and hedge funds own 89.39% of the company's stock.

幾家機構投資者和對衝基金最近調整了對PHR的持股。AssetMark Inc.在第二季度將其在Phreesia的持股增加了42.2%。AssetMark Inc.在此期間增持了500股,目前持有1,685股該公司股票,價值42,000美元。US Bancorp DE在第二季度將其在Phreesia的持股增加了6.6%。US Bancorp DE現在擁有該公司8270股股票,價值20.7萬美元,在此期間又購買了509股。Advisor Group Holdings Inc.在第四季度將其在Phreesia的持股增加了63.4%。Advisor Group Holdings Inc.在此期間增持了512股,現在擁有1,319股該公司股票,價值55,000美元。Edmond de Rothschild Holding S.A.在第一季度將其在Phreesia的持股增加了2.2%。Edmond de Rothschild Holding S.A.在此期間增持了800股,現在持有37,650股該公司股票,價值99.2萬美元。最後,亞利桑那州退休系統在第二季度將其在Phreesia的持有量增加了6.6%。亞利桑那州立退休系統在此期間額外購買了815股,現在擁有13,192股該公司股票,價值33萬美元。機構投資者和對衝基金持有該公司89.39%的股票。

About Phreesia

關於Phreesia

(Get Rating)

(獲取評級)

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments.

Phreesia,Inc.為美國和加拿大的醫療保健行業提供基於SaaS的集成軟件和支付平臺。其Phreesia平臺提供了一套管理患者入院流程的解決方案,以及用於處理患者付款的集成支付解決方案。

Recommended Stories

推薦故事

  • Get a free copy of the StockNews.com research report on Phreesia (PHR)
  • No One Told These 3 Stocks It's a Down Week
  • Is There a Cure for What is Ailing Teladoc Stock?
  • Why Medical Products Maker Repligen May Be A Potential Buy
  • At 10%, Is Arbor Realty Trust Dividend Worth It?
  • Investors Should Tune Into RF Industries
  • 免費獲取StockNews.com關於Phreesia的研究報告(PHR)
  • 沒有人告訴這三隻股票這是下跌的一週
  • 有什麼辦法可以治癒Teladoc股票的問題嗎?
  • 為什麼醫療產品製造商Repligen可能成為潛在收購對象
  • 在10%的水平上,Arbor Realty Trust的股息值得嗎?
  • 投資者應關注RF Industries

Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.

接受《Phreesia Daily》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Phreesia和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論